Fuat Demirkıran

2.1k total citations
76 papers, 775 citations indexed

About

Fuat Demirkıran is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Fuat Demirkıran has authored 76 papers receiving a total of 775 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Reproductive Medicine, 39 papers in Obstetrics and Gynecology and 19 papers in Surgery. Recurrent topics in Fuat Demirkıran's work include Ovarian cancer diagnosis and treatment (37 papers), Endometrial and Cervical Cancer Treatments (29 papers) and Endometriosis Research and Treatment (16 papers). Fuat Demirkıran is often cited by papers focused on Ovarian cancer diagnosis and treatment (37 papers), Endometrial and Cervical Cancer Treatments (29 papers) and Endometriosis Research and Treatment (16 papers). Fuat Demirkıran collaborates with scholars based in Türkiye, United States and United Kingdom. Fuat Demirkıran's co-authors include Tugan Beşe, Macit Arvas, D. Kösebay, Şennur İlvan, İlker Kahramanoğlu, Engin Oral, Hakan Erenel, Onur Güralp, Pelin Öçal and İsmail Çepni and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Fuat Demirkıran

70 papers receiving 747 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fuat Demirkıran Türkiye 16 451 436 166 132 118 76 775
Taek Sang Lee South Korea 17 466 1.0× 417 1.0× 154 0.9× 119 0.9× 158 1.3× 53 842
Shannon Salvador Canada 18 580 1.3× 621 1.4× 207 1.2× 143 1.1× 131 1.1× 74 959
Mariam AlHilli United States 15 647 1.4× 567 1.3× 134 0.8× 209 1.6× 154 1.3× 65 978
Uğur Saygılı Türkiye 19 397 0.9× 463 1.1× 231 1.4× 131 1.0× 140 1.2× 56 937
Mustafa Zelal Muallem Germany 15 265 0.6× 274 0.6× 201 1.2× 112 0.8× 67 0.6× 59 558
Maria Giovanna Salerno Italy 14 501 1.1× 438 1.0× 336 2.0× 143 1.1× 172 1.5× 26 854
Bahadır Saatli Türkiye 13 334 0.7× 366 0.8× 82 0.5× 57 0.4× 91 0.8× 37 601
Tugan Beşe Türkiye 16 489 1.1× 486 1.1× 129 0.8× 94 0.7× 85 0.7× 59 771
Jan Hauspy Belgium 16 395 0.9× 209 0.5× 164 1.0× 185 1.4× 216 1.8× 30 710
Santiago Domingo Spain 16 369 0.8× 331 0.8× 322 1.9× 152 1.2× 65 0.6× 74 776

Countries citing papers authored by Fuat Demirkıran

Since Specialization
Citations

This map shows the geographic impact of Fuat Demirkıran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuat Demirkıran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuat Demirkıran more than expected).

Fields of papers citing papers by Fuat Demirkıran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuat Demirkıran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuat Demirkıran. The network helps show where Fuat Demirkıran may publish in the future.

Co-authorship network of co-authors of Fuat Demirkıran

This figure shows the co-authorship network connecting the top 25 collaborators of Fuat Demirkıran. A scholar is included among the top collaborators of Fuat Demirkıran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuat Demirkıran. Fuat Demirkıran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taşkın, Salih, Fuat Demirkıran, Mete Güngör, et al.. (2024). Risk factors for the involvement of sentinel lymph nodes in endometrial cancer (TRSGO-SLN-010). International Journal of Gynecological Cancer. 35(1). 100041–100041.
3.
Oaknin, Ana, Rebecca Kristeleit, Myong Cheol Lim, et al.. (2022). 2022-LBA-325-ESGO Patients with newly diagnosed ovarian cancer treated with maintenance rucaparib: exploratory biomarker analysis from the phase 3 ATHENA-MONO study (GOG-3020/ENGOT-ov45; NCT03522246). International Journal of Gynecological Cancer. 32. A472–A472. 1 indexed citations
4.
Vatansever, Doğan, Çağatay Taşkıran, Mehmet Mutlu Meydanlı, et al.. (2021). Impact of cytoreductive surgery on survival of patients with low‐grade serous ovarian carcinoma: A multicentric study of Turkish Society of Gynecologic Oncology (TRSGO‐OvCa‐001). Journal of Surgical Oncology. 123(8). 1801–1810. 6 indexed citations
5.
Meydanlı, Mehmet Mutlu, Hüseyin Akıllı, Mehmet Gökçü, et al.. (2020). Does lymph node ratio have any prognostic significance in maximally cytoreduced node-positive low-grade serous ovarian carcinoma?. Archives of Gynecology and Obstetrics. 302(1). 183–190. 5 indexed citations
6.
Kahramanoğlu, İlker, et al.. (2018). A Very Rare Case: HPV‐Negative Vulvar Cancer in an Adolescent. Case Reports in Obstetrics and Gynecology. 2018(1). 1816782–1816782.
7.
Oral, Engin, Övgü Aydın, Banu Kumbak, et al.. (2018). Concomitant endometriosis in malignant and borderline ovarian tumours*. Journal of Obstetrics and Gynaecology. 38(8). 1104–1109. 14 indexed citations
8.
Demirkıran, Fuat, et al.. (2018). Simple vaginal trachelectomy for early stage cervical cancer: A tertiary cancer center experience. Ginekologia Polska. 89(9). 475–480. 12 indexed citations
9.
Kahramanoğlu, İlker, Gönül Şimşek, Remise Gelışgen, et al.. (2018). YKL-40 in the diagnosis, prediction of prognosis, and platinum sensitivity in serous epithelial ovarian cancer. Journal of Turkish Society of Obstetric and Gynecology. 15(3). 177–181. 5 indexed citations
10.
Arvas, Macit, Hamdullah Sözen, İlker Kahramanoğlu, et al.. (2016). Tertiary Cytoreduction for Recurrent Epithelial Ovarian Cancer: a Multicenter Study in Turkey. Asian Pacific Journal of Cancer Prevention. 17(4). 1909–1915. 4 indexed citations
11.
Demirkıran, Fuat, Samet Topuz, İlker Kahramanoğlu, et al.. (2016). Surgical Treatment of Metastatic Ovarian Tumors from Extragenital Primary Sites. International Journal of Gynecological Cancer. 26(4). 688–696. 17 indexed citations
12.
İnce, Ümit, et al.. (2014). Embryonal rhabdomyosarcoma of the uterine cervix in a pregnant woman. Taiwanese Journal of Obstetrics and Gynecology. 53(3). 423–425. 5 indexed citations
13.
Öksüz, Didem Çolpan, et al.. (2012). UNUSUAL PRESENTATION OF CERVICAL CARCINOMA METASTASIS TO THE BREAST: A CASE REPORT AND REVIEW OF THE LITERATURE. SHILAP Revista de lepidopterología. 1 indexed citations
14.
Beşe, Tugan, et al.. (2009). Transtubal Transport of Carcinoma Cells Into the Peritoneal Cavity After Saline Infusion via Transcervical Route in Patients With Endometrial Carcinoma. International Journal of Gynecological Cancer. 19(4). 682–685. 5 indexed citations
15.
Şenay, Şahın, et al.. (2007). Surgical Management of Intravenous Leiomyoma with Cardiac Extension. Do We Need Total Circulatory Arrest?. The Thoracic and Cardiovascular Surgeon. 55(5). 322–323. 4 indexed citations
17.
Tulunay, Gökhan, Macit Arvas, Fuat Demirkıran, et al.. (2004). Primary fallopian tube carcinoma: a retrospective multicenter study.. PubMed. 25(5). 611–4. 4 indexed citations
18.
Arvas, Macit, Fatih Köse, Altay Gezer, et al.. (2004). Radical versus conservative surgery for vulvar carcinoma. International Journal of Gynecology & Obstetrics. 88(2). 127–133. 19 indexed citations
19.
Oral, Engin, Şennur İlvan, Tugan Beşe, et al.. (2003). Prevalence of endometriosis in malignant epithelial ovary tumours. European Journal of Obstetrics & Gynecology and Reproductive Biology. 109(1). 97–101. 73 indexed citations
20.
Şen, Cihat, et al.. (1992). FHR monitoring and perinatal mortality in high-risk pregnancies. European Journal of Obstetrics & Gynecology and Reproductive Biology. 44(1). 59–63. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026